Shares of Owens & Minor, Inc. (NYSE:OMI - Get Free Report) have been assigned an average rating of "Hold" from the seven research firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, one has given a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $7.6250.
OMI has been the subject of a number of research analyst reports. Citigroup reaffirmed a "buy" rating and issued a $7.00 price target (down from $11.00) on shares of Owens & Minor in a report on Tuesday, August 12th. Baird R W raised Owens & Minor from a "hold" rating to a "strong-buy" rating in a report on Friday, August 8th. Bank of America cut their price target on Owens & Minor from $7.50 to $4.75 and set an "underperform" rating for the company in a report on Tuesday, August 12th. UBS Group set a $7.00 price target on Owens & Minor in a report on Wednesday, August 13th. Finally, JPMorgan Chase & Co. cut their price target on Owens & Minor from $7.00 to $6.00 and set an "underweight" rating for the company in a report on Wednesday.
Get Our Latest Stock Report on OMI
Owens & Minor Stock Down 2.6%
Shares of NYSE OMI opened at $4.88 on Thursday. The business has a fifty day moving average of $7.20 and a two-hundred day moving average of $7.57. The company has a debt-to-equity ratio of 3.32, a quick ratio of 0.83 and a current ratio of 0.86. Owens & Minor has a 52-week low of $4.56 and a 52-week high of $16.47. The stock has a market cap of $377.09 million, a PE ratio of -0.31 and a beta of 1.04.
Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings results on Monday, August 11th. The company reported $0.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.27 by ($0.01). Owens & Minor had a negative net margin of 13.78% and a positive return on equity of 26.59%. The business had revenue of $681.90 million during the quarter, compared to the consensus estimate of $2.73 billion. During the same period in the prior year, the firm earned $0.36 earnings per share. The business's quarterly revenue was up 3.3% compared to the same quarter last year. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. As a group, equities research analysts expect that Owens & Minor will post 1.51 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, major shareholder Coliseum Capital Management, L acquired 492,852 shares of the company's stock in a transaction on Thursday, August 14th. The stock was purchased at an average cost of $5.31 per share, with a total value of $2,617,044.12. Following the acquisition, the insider owned 13,100,807 shares of the company's stock, valued at $69,565,285.17. This trade represents a 3.91% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last three months, insiders bought 1,537,852 shares of company stock worth $8,099,544. Insiders own 3.69% of the company's stock.
Institutional Trading of Owens & Minor
Several institutional investors and hedge funds have recently added to or reduced their stakes in OMI. DekaBank Deutsche Girozentrale raised its holdings in Owens & Minor by 76.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $28,000 after purchasing an additional 1,356 shares during the last quarter. Versant Capital Management Inc increased its stake in shares of Owens & Minor by 537.6% in the 1st quarter. Versant Capital Management Inc now owns 3,201 shares of the company's stock valued at $29,000 after acquiring an additional 2,699 shares during the last quarter. Parallel Advisors LLC increased its stake in shares of Owens & Minor by 1,387.0% in the 1st quarter. Parallel Advisors LLC now owns 3,316 shares of the company's stock valued at $30,000 after acquiring an additional 3,093 shares during the last quarter. Quarry LP bought a new stake in shares of Owens & Minor in the 1st quarter valued at about $34,000. Finally, Headlands Technologies LLC bought a new stake in shares of Owens & Minor in the 1st quarter valued at about $55,000. 98.04% of the stock is owned by institutional investors.
About Owens & Minor
(
Get Free Report)
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.